S3 Episode 5: Revolutionizing Small Cell Lung Cancer: A Deep Dive into Immunotherapy Advancements With Dr Hossein Borghaei
Medscape InDiscussion: Lung Cancer
by Medscape
1d ago
Drs Jacob Sands and Hossein Borghaei discuss small cell lung cancer, including breakthroughs and challenges in immunotherapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999031. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer https://pubmed.ncbi.nlm.nih.gov/30280641/ Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide in ..read more
Visit website
S3 Episode 4: The Future of Antibody-Drug Conjugates in Lung Cancer Treatment
Medscape InDiscussion: Lung Cancer
by Medscape
1M ago
Drs Jacob Sands and Benjamin P. Levy discuss antibody-drug conjugates in lung cancer treatment, including differences in efficacy, toxicity profiles, and what the future holds. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999030. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress https://pubmed.ncbi.nlm.nih.gov/37163707/ TROP-2 Directed Antibody-Drug Co ..read more
Visit website
S3 Episode 3: Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health
Medscape InDiscussion: Lung Cancer
by Medscape
2M ago
Drs Jacob Sands and Narjust Florez discuss the nuances of treating women with lung cancer, including screening, treatment, and sexual and reproductive health. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/999029). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources The Role of Cultural Humility in Addressing Disparities in Lung Cancer Treatment: How Can Physicians Make a Difference? https://www.medscape.com/viewartic ..read more
Visit website
S3 Episode 2: Improving Lung Cancer Patient Care Through Collaboration, Psychology, and Communication
Medscape InDiscussion: Lung Cancer
by Medscape
3M ago
Drs Jacob Sands and Donald L. Rosenstein discuss the psychology of lung cancer and how to effectively communicate with patients about diagnosis, treatment, and expectations. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/999028). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Lung Cancer https://www.medscape.com/resource/lungcancer/rc-lungcancer2 The Flourishing Scholarship of Psychosocial Oncology Viewed Across ..read more
Visit website
S3 Episode 1: What Are the Latest Improvements in Targeted Therapy Options and Diagnostic Technology for Lung Cancer Patients?
Medscape InDiscussion: Lung Cancer
by Medscape
3M ago
Drs Jacob Sands and Julia Rotow discuss the latest breakthroughs in lung cancer treatment, including targeted therapy options, toxicities, and diagnostic technology. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/999027). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Young Adults and Lung Cancer: Testing and Treatment Options for a Population That Does Not Qualify for Screening https://www.medscape.com/viewartic ..read more
Visit website
S2 Episode 6: How Can Clinicians Recognize and Address Stigma and Bias to Improve Treatment Disparities in Lung Cancer?
Medscape InDiscussion: Lung Cancer
by Medscape
1y ago
Drs Jacob Sands and Christopher Lathan, MD, discuss stigma, clinician bias, financial toxicity, and treatment disparities in lung cancer, including helpful practices such as "following the no." Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984264). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Lung Cancer https://www.medscape.com/resource/lungcancer/rc-lungcancer2 Racial and Ethnic Disparities https://www.lung ..read more
Visit website
S2 Episode 5: Immunotherapy, Next-Generation Sequencing, and Shared Decision-Making in the Treatment of Non–Small Cell Lung Cancer
Medscape InDiscussion: Lung Cancer
by Medscape
1y ago
Drs Jacob Sands and Stephen V. Liu discuss immunotherapy, biomarkers, next-generation sequencing, shared decision-making, and improving outcomes in the treatment of non–small cell lung cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984262). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Pembrolizumab Versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Metastatic Non-Small-C ..read more
Visit website
S2 Episode 1: Are We Ready to Use the Word "Cure" When Talking About Small Cell Lung Cancer Treatment?
Medscape InDiscussion: Lung Cancer
by Medscape
1y ago
Drs Jacob Sands and Jared Weiss discuss subtypes; ongoing clinical trials; durable, ongoing responses to therapy; and the potential for using the word "cure" in the treatment of small cell lung cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984257). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Immunotherapy and Lung Cancer Treatment https://www.medscape.com/viewarticle/969534 Small Cell Lung Cancer (SCL ..read more
Visit website
Small Cell Lung Cancer: What Are the First-line and Second-line Treatment Options?
Medscape InDiscussion: Lung Cancer
by Medscape
1y ago
Drs Jacob Sands and Lauren Byers discuss the treatment options for patients diagnosed with small cell lung cancer and the future possibility of durable responses. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/969536). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US health care professionals. Resources FDA Approval Summary: Atezolizumab and Durvalumab in Combination With Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer https://ww ..read more
Visit website
Immunotherapy and Lung Cancer Treatment
Medscape InDiscussion: Lung Cancer
by Medscape
1y ago
Drs Jacob Sands and Jared Weiss discuss immunotherapy, including the importance of genomic testing, recent studies, new regimens, and the future of lung cancer treatment. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/969534). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US health care professionals. Resources Severe Immune-Related Adverse Events Are Common With Sequential PD-(L)1 Blockade and Osimertinib https://www.annalsofoncology.org/article/S092 ..read more
Visit website

Follow Medscape InDiscussion: Lung Cancer on FeedSpot

Continue with Google
Continue with Apple
OR